Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02534415Phase 4
Key facts
Phase 4, randomised, single-blind trial of hyaluronic acid sodium composite gel for injection in surgical wound (3 arms), sponsored by Marmara University. Primary endpoints: Pain at 21 days and Burning Sensation at 21 days. Started Aug 2013; status: completed.
Periodontal dressing
Standard of care dressing applied at baseline and day 3
0.2% Hyaluronic acid
0.2% HA gel applied under dressing at baseline and day 3
0.8% Hyaluronic acid
0.8% HA gel applied under dressing at baseline and day 3
Pain
Burning Sensation
Color match
Consistency
Epithelialization
Beyond the preview
Full results, competitive context and analysis are in the Gosset platform.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02534415.